Geron Corp. (GERN)
1.52
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Geron Shareholders Equity (Quarterly) : 218.61M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 218.61M |
| March 31, 2026 | 229.11M |
| December 31, 2025 | 225.87M |
| September 30, 2025 | 248.71M |
| June 30, 2025 | 259.53M |
| March 31, 2025 | 268.24M |
| December 31, 2024 | 280.32M |
| September 30, 2024 | 292.28M |
| June 30, 2024 | 306.70M |
| March 31, 2024 | 344.87M |
| December 31, 2023 | 247.95M |
| September 30, 2023 | 290.61M |
| June 30, 2023 | 298.43M |
| March 31, 2023 | 326.06M |
| December 31, 2022 | 80.00M |
| September 30, 2022 | 108.17M |
| June 30, 2022 | 142.05M |
| March 31, 2022 | 97.49M |
| December 31, 2021 | 126.42M |
| September 30, 2021 | 151.55M |
| June 30, 2021 | 176.21M |
| March 31, 2021 | 201.16M |
| December 31, 2020 | 210.95M |
| September 30, 2020 | 232.83M |
| June 30, 2020 | 250.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 120.81M |
| December 31, 2019 | 135.16M |
| September 30, 2019 | 152.39M |
| June 30, 2019 | 157.04M |
| March 31, 2019 | 169.41M |
| December 31, 2018 | 177.73M |
| September 30, 2018 | 183.47M |
| June 30, 2018 | 178.36M |
| March 31, 2018 | 101.13M |
| December 31, 2017 | 103.80M |
| September 30, 2017 | 108.27M |
| June 30, 2017 | 113.01M |
| March 31, 2017 | 117.25M |
| December 31, 2016 | 122.38M |
| September 30, 2016 | 128.91M |
| June 30, 2016 | 130.30M |
| March 31, 2016 | 136.48M |
| December 31, 2015 | 142.13M |
| September 30, 2015 | 147.89M |
| June 30, 2015 | 118.36M |
| March 31, 2015 | 125.18M |
| December 31, 2014 | 130.71M |
| September 30, 2014 | 137.18M |
| June 30, 2014 | 144.58M |
| March 31, 2014 | 150.89M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Precigen, Inc. | 43.58M |
| Editas Medicine, Inc. | 105.28M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 519.01M |
| Total Liabilities (Quarterly) | 300.40M |
| Debt to Equity Ratio | 1.152 |
| Current Ratio | 6.915 |
| Net Debt Paydown Yield | -0.10% |